Latest Global Markets News

RWC’s H1 FY26 results reveal a 4.6% sales decline and a 22.5% drop in adjusted EBITDA, largely due to US tariffs and regional market pressures. The company is countering challenges by opening a new manufacturing facility in Mexico and expects modest sales recovery in H2 FY26.

PM Capital Global Opportunities Fund Limited has raised its full-year dividend guidance to 13.5 cents per share following a stellar 22% portfolio return in the first half of FY26, significantly outperforming key market indices.

Tivan Limited has taken significant steps forward at its 100% owned Molyhil Tungsten Project, awarding major engineering contracts and preparing for a maiden drilling program aimed at expanding its resource base.

MFF Capital Investments reported a 45% drop in net profit for the half year to December 2025 but declared a higher fully franked dividend, marking a milestone in its operational independence and strategic growth.

Breville Group Limited has reported a record half-year revenue of $1.1 billion, driven by strong coffee sales and new market growth, while successfully managing US tariff impacts to maintain flat EBIT year-on-year.

Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.

CSL Limited announces the retirement of CEO Dr Paul McKenzie, with veteran executive Gordon Naylor appointed as interim CEO and Managing Director. The leadership change marks a new chapter for the biotech giant amid ongoing strategic transformation.

Regal Partners Global Investments Limited (ASX, RG1) has reported a remarkable turnaround with a $103.5 million profit after tax for the half-year ended 31 December 2025, alongside a 6.0 cent fully franked interim dividend and an active share buy-back program.

Macquarie Group reports solid 3Q26 results with robust profit growth across divisions and a strong capital surplus, underpinned by strategic technology investments and regulatory compliance.

Macquarie Group has reported a solid third quarter for FY26, with significant profit gains in asset management and capital divisions, alongside steady growth in banking services. The group maintains a strong capital buffer, positioning itself well despite a cautious economic outlook.

West Cobar Metals has confirmed that antimony grades at its Bulla Park project in NSW are higher than previously reported, thanks to a new assay method. This discovery could enhance the deposit’s value amid rising demand for critical minerals.

Paradigm Biopharmaceuticals has entered a binding agreement with AVet Health to co-develop and license a novel oral therapy for veterinary osteoarthritis in Australia and New Zealand, unlocking new market potential while advancing its human clinical trials.